IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 244 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $33,362,000 | -49.4% | 1,747,622 | -34.7% | 2.57% | -51.3% |
Q3 2021 | $65,948,000 | +18.5% | 2,674,299 | +25.1% | 5.28% | +2.9% |
Q2 2021 | $55,631,000 | +33.8% | 2,137,999 | +62.8% | 5.13% | +53.9% |
Q1 2021 | $41,570,000 | -31.8% | 1,312,999 | 0.0% | 3.33% | -28.9% |
Q4 2020 | $60,923,000 | +40.9% | 1,312,999 | 0.0% | 4.69% | +20.9% |
Q3 2020 | $43,224,000 | +19.9% | 1,312,999 | 0.0% | 3.88% | +22.6% |
Q2 2020 | $36,042,000 | -31.2% | 1,312,999 | -25.0% | 3.16% | -46.7% |
Q1 2020 | $52,406,000 | +8.1% | 1,750,665 | 0.0% | 5.94% | -26.9% |
Q4 2019 | $48,458,000 | +52.1% | 1,750,665 | 0.0% | 8.13% | -18.4% |
Q3 2019 | $31,862,000 | -40.6% | 1,750,665 | -20.0% | 9.96% | -27.5% |
Q2 2019 | $53,658,000 | +157.8% | 2,188,331 | 0.0% | 13.75% | +174.4% |
Q1 2019 | $20,811,000 | +7.5% | 2,188,331 | 0.0% | 5.01% | +0.3% |
Q4 2018 | $19,367,000 | -21.3% | 2,188,331 | 0.0% | 5.00% | +10.8% |
Q3 2018 | $24,619,000 | -12.1% | 2,188,331 | 0.0% | 4.51% | -22.3% |
Q2 2018 | $28,011,000 | -24.3% | 2,188,331 | 0.0% | 5.80% | -5.5% |
Q1 2018 | $36,983,000 | +111.2% | 2,188,331 | 0.0% | 6.14% | +116.2% |
Q4 2017 | $17,507,000 | +3.2% | 2,188,331 | 0.0% | 2.84% | -53.1% |
Q3 2017 | $16,960,000 | +11.5% | 2,188,331 | 0.0% | 6.05% | -22.4% |
Q2 2017 | $15,209,000 | – | 2,188,331 | – | 7.80% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |